中国中免：2025年度业绩快报公告

Group 1 - The core viewpoint of the article is that China National Pharmaceutical Group Corporation (China National Medicine) reported its financial performance for the fiscal year 2025, highlighting significant revenue and profit figures [1] - The company achieved a total operating revenue of 5,369,357.92 thousand yuan, which translates to approximately 5.37 billion yuan [1] - The net profit attributable to shareholders of the listed company was reported at 358,583.85 thousand yuan, equivalent to about 358.58 million yuan [1]